Xenetic Biosciences (XBIO) Tax Rate (2019 - 2021)
Xenetic Biosciences' (XBIO) quarterly Tax Rate came in at 215.39% in Q4 2020, down 24023.0% YoY from N/an in Q1 2020, and down 873.35% on a QoQ basis from 27.85% in Q3 2020.
Xenetic Biosciences (XBIO) Tax Rate (2019 - 2021) Analysis & Trends
Xenetic Biosciences (XBIO) has 2 years of Tax Rate data on file, last reported at 215.39% in Q4 2020.
- Quarterly Tax Rate fell 24023.0% year-over-year to 215.39% in Q4 2020, while the trailing twelve-month figure through Dec 2021 was 0.35% (down 43.0% YoY) and the FY2020 annual result came in at 0.53%, down 169.0% from the prior year.
- Tax Rate fell to 215.39% in Q4 2020, from 27.85% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 27.85% in Q3 2020 to a low of 215.39% in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 7.49% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -16.71% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 34.12% |
| 10 | Xenetic Biosciences | 7.59 Mn | 1.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 62.95% |
| Dec 31, 2021 | 62.95% |
| Dec 31, 2021 | 62.95% |
| Dec 31, 2020 | -215.39% |
| Dec 31, 2020 | -215.39% |
| Dec 31, 2020 | -215.39% |
| Sep 30, 2020 | 27.85% |
| Sep 30, 2020 | 27.85% |
| Sep 30, 2020 | 27.85% |
| Dec 31, 2019 | 24.84% |
| Dec 31, 2019 | 24.84% |
| Dec 31, 2019 | 24.84% |